Long-term estrogen deprivation leads to elevation of Dickkopf-1 and dysregulation of Wnt/β-Catenin signaling in hippocampal CA1 neurons

Steroids

Volumn 78, Issue 6, 2013, Pages 624-632

  Scott, Erin L ^a   Zhang, Quan Guang ^a   Han, Dong ^a   Desai, Bhavna N ^a   Brann, Darrell W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Dkk1; Estrogen; Hippocampus; Long term estrogen deprivation; Menopause; Neuroprotection

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; ESTRADIOL; PLACEBO; STRESS ACTIVATED PROTEIN KINASE; SURVIVIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HIPPOCAMPAL CA1 REGION; MENOPAUSE; NERVE CELL; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; RAT; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CA1 REGION, HIPPOCAMPAL; ESTRADIOL; FEMALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; WNT SIGNALING PATHWAY;

RATTUS;

EID: 84876668606     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.11.004     Document Type: Conference Paper

References (67)

1. D.W. Brann, K. Dhandapani, C. Wakade, V.B. Mahesh, and M.M. Khan Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications Steroids 72 2007 381 405
2. J.W. Simpkins, G. Rajakumar, Y.Q. Zhang, C.E. Simpkins, D. Greenwald, and C.J. Yu Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat J Neurosurg 87 1997 724 730
3. J.W. Simpkins, M. Singh, C. Brock, and A.M. Etgen Neuroprotection and estrogen receptors Neuroendocrinology 96 2012 119 130
4. D. Lebesgue, V. Chevaleyre, R.S. Zukin, and A.M. Etgen Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection Steroids 74 2009 555 561
5. J.W. Simpkins, E. Perez, X. Wang, S. Yang, Y. Wen, and M. Singh The potential for estrogens in preventing Alzheimer's disease Ther Adv Neurol Disord 2 2009 31 49
6. J.W. Simpkins, P.S. Green, K.E. Gridley, M. Singh, N.C. de Fiebre, and G. Rajakumar Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease Am J Med 103 1997 19S 25S
7. J.W. Simpkins, K.D. Yi, and S.H. Yang Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens Front Neuroendocrinol 30 2009 93 105
8. R.D. Brinton Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease Adv Drug Deliv Rev 60 2008 1504 1511
9. J.H. Morrison, R.D. Brinton, P.J. Schmidt, and A.C. Gore Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women J Neurosci 26 2006 10332 10348
10. M. Niewada, A. Kobayashi, P.A. Sandercock, B. Kaminski, and A. Czlonkowska Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial Neuroepidemiology 24 2005 123 128
11. J. Roquer, A.R. Campello, and M. Gomis Sex differences in first-ever acute stroke Stroke 34 2003 1581 1585
12. S.J. Murphy, L.D. McCullough, and J.M. Smith Stroke in the female: role of biological sex and estrogen ILAR J 45 2004 147 159
13. A. Di Carlo, M. Lamassa, M. Baldereschi, G. Pracucci, A.M. Basile, and C.D. Wolfe Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry Stroke 34 2003 1114 1119
14. W.A. Rocca, L.T. Shuster, B.R. Grossardt, D.M. Maraganore, B.S. Gostout, and Y.E. Geda Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging Womens Health (Lond Engl) 5 2009 39 48
15. W.A. Rocca, B.R. Grossardt, and L.T. Shuster Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity Brain Res 1379 2011 188 198
16. W.A. Rocca, B.R. Grossardt, and L.T. Shuster Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis Neurodegener Dis 7 2010 163 166
17. C.M. Rivera, B.R. Grossardt, D.J. Rhodes, and W.A. Rocca Increased mortality for neurological and mental diseases following early bilateral oophorectomy Neuroepidemiology 33 2009 32 40
18. S. Wassertheil-Smoller, S.L. Hendrix, M. Limacher, G. Heiss, C. Kooperberg, and A. Baird Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial JAMA 289 2003 2673 2684
19. S.A. Shumaker, C. Legault, S.R. Rapp, L. Thal, R.B. Wallace, and J.K. Ockene Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 2003 2651 2662
20. S.M. Harman, E.A. Brinton, T. Clarkson, C.B. Heward, H.S. Hecht, and R.H. Karas Is the WHI relevant to HRT started in the perimenopause? Endocrine 24 2004 195 202
21. P.M. Maki Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 138 2006 1027 1030
22. R.D. Brinton Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action Ann NY Acad Sci 1052 2005 57 74
23. R.D. Brinton The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications Trends Neurosci 31 2008 529 537
24. B.B. Sherwin The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol 19 2007 77 81
25. C.L. Busceti, F. Biagioni, E. Aronica, B. Riozzi, M. Storto, and G. Battaglia Induction of the Wnt inhibitor, Dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy Epilepsia 48 2007 694 705
26. A. Caricasole, A. Copani, F. Caraci, E. Aronica, A.J. Rozemuller, and A. Caruso Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain J Neurosci 24 2004 6021 6027
27. G.V. De Ferrari, and R.T. Moon The ups and downs of Wnt signaling in prevalent neurological disorders Oncogene 25 2006 7545 7553
28. F. Mastroiacovo, C.L. Busceti, F. Biagioni, S.G. Moyanova, M.H. Meisler, and G. Battaglia Induction of the Wnt antagonist, Dickkopf-1, contributes to the development of neuronal death in models of brain focal ischemia J Cereb Blood Flow Metab 29 2009 264 276
29. M.C. Rosi, I. Luccarini, C. Grossi, A. Fiorentini, M.G. Spillantini, and A. Prisco Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease J Neurochem 112 2010 1539 1551
30. Q.G. Zhang, R. Wang, M. Khan, V. Mahesh, and D.W. Brann Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation J Neurosci 28 2008 8430 8441
31. R.A. Boonen, P. van Tijn, and D. Zivkovic Wnt signaling in Alzheimer's disease: up or down, that is the question Ageing Res Rev 8 2009 71 82
32. I. Cappuccio, A. Calderone, C.L. Busceti, F. Biagioni, F. Pontarelli, and V. Bruno Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death J Neurosci 25 2005 2647 2657
33. B.T. MacDonald, M. Adamska, and M.H. Meisler Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6 Development 131 2004 2543 2552
34. B.T. MacDonald, D.M. Joiner, S.M. Oyserman, P. Sharma, S.A. Goldstein, and X. He Bone mass is inversely proportional to Dkk1 levels in mice Bone 41 2007 331 339
35. J.M. Ordy, T.M. Wengenack, P. Bialobok, P.D. Coleman, P. Rodier, and R.B. Baggs Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia Exp Neurol 119 1993 128 139
36. M.P. Mattson, P.B. Guthrie, and S.B. Kater Intrinsic factors in the selective vulnerability of hippocampal pyramidal neurons Prog Clin Biol Res 317 1989 333 351
37. W.A. Pulsinelli, and J.B. Brierley A new model of bilateral hemispheric ischemia in the unanesthetized rat Stroke 10 1979 267 272
38. Q.G. Zhang, L. Raz, R. Wang, D. Han, L. De Sevilla, and F. Yang Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation J Neurosci 29 2009 13823 13836
39. M. De Butte-Smith, R.S. Zukin, and A.M. Etgen Effects of global ischemia and estradiol pretreatment on phosphorylation of Akt, CREB and STAT3 in hippocampal CA1 of young and middle-aged female rats Brain Res 1471 2012 118 128
40. M. Bacigaluppi, G. Comi, and D.M. Hermann Animal models of ischemic stroke. Part two: modeling cerebral ischemia Open Neurol J 4 2010 34 38
41. Z. He, Y.J. He, A.L. Day, and J.W. Simpkins Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: perfusion-dependent and -independent mechanisms J Neurol Sci 193 2002 79 87
42. Z. Wang, S. Fukuda, and L.M. Pelus Survivin regulates the p53 tumor suppressor gene family Oncogene 23 2004 8146 8153
43. Q.G. Zhang, D. Han, R.M. Wang, Y. Dong, F. Yang, and R.K. Vadlamudi From the Cover: C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-{alpha} and the critical period hypothesis of estrogen neuroprotection PNAS 108 2011 E617 E624
44. Q.G. Zhang, H. Tian, H.C. Li, and G.Y. Zhang Antioxidant N-acetylcysteine inhibits the activation of JNK3 mediated by the GluR6-PSD95-MLK3 signaling module during cerebral ischemia in rat hippocampus Neurosci Lett 408 2006 159 164
45. W.A. Pulsinelli, and A.M. Buchan The four-vessel occlusion rat model: method for complete occlusion of vertebral arteries and control of collateral circulation Stroke 19 1988 913 914
46. C. Wakade, M.M. Khan, L.M. De Sevilla, Q.G. Zhang, V.B. Mahesh, and D.W. Brann Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase Endocrinology 149 2008 367 379
47. B.L. Bennett, D.T. Sasaki, B.W. Murray, E.C. O'Leary, S.T. Sakata, and W. Xu SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Proc Natl Acad Sci USA 98 2001 13681 13686
48. K. Xu, X. Sun, M.A. Puchowicz, and J.C. LaManna Increased sensitivity to transient global ischemia in aging rat brain Adv Exp Med Biol 599 2007 199 206
49. K. Xu, M.A. Puchowicz, X. Sun, and J.C. LaManna Decreased brainstem function following cardiac arrest and resuscitation in aged rat Brain Res 1328 2010 181 189
50. P.K. Shetty, F. Galeffi, and D.A. Turner Age-induced alterations in hippocampal function and metabolism Aging Dis 2 2011 196 218
51. M. Di Napoli, and I.M. Shah Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective J Aging Res 2011 2011 857484
52. S.E. Thal, C. Zhu, S.C. Thal, K. Blomgren, and N. Plesnila Role of apoptosis inducing factor (AIF) for hippocampal neuronal cell death following global cerebral ischemia in mice Neurosci Lett 499 2011 1 3
53. S. Suman, M. Maniar, A.J. Fornace Jr., and K. Datta Administration of ON 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response Radiat Oncol 7 2012 6
54. G.Y. Li, B. Fan, and T.H. Ma Visible light may directly induce nuclear DNA damage triggering the death pathway in RGC-5 cells Mol Vis 17 2011 3279 3289
55. K. Xu, M.A. Puchowicz, X. Sun, and J.C. LaManna Mitochondrial dysfunction in aging rat brain following transient global ischemia Adv Exp Med Biol 614 2008 379 386
56. T. Inagaki, N. Kaneko, R.S. Zukin, P.E. Castillo, and A.M. Etgen Estradiol attenuates ischemia-induced death of hippocampal neurons and enhances synaptic transmission in aged, long-term hormone-deprived female rats PLoS One 7 2012 e38018
57. J.X. Wang, and S. Zheng Caspase-3 and survivin expression in pediatric neuroblastoma and their roles in apoptosis Chin Med J (Engl) 117 2004 1821 1824
58. S. Shin, B.J. Sung, Y.S. Cho, H.J. Kim, N.C. Ha, and J.I. Hwang An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7 Biochemistry 40 2001 1117 1123
59. Y.H. Li, C. Wang, K. Meng, L.B. Chen, and X.J. Zhou Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma World J Gastroenterol 10 2004 1984 1988
60. J. Wang, J. Shou, and X. Chen Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53 Oncogene 19 2000 1843 1848
61. L. Raz, Q.G. Zhang, D. Han, Y. Dong, L. De Sevilla, and D.W. Brann Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen PLoS One 6 2011 e27039
62. L. Grotewold, and U. Ruther The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death EMBO J 21 2002 966 975
63. L.T. Shuster, D.J. Rhodes, B.S. Gostout, B.R. Grossardt, and W.A. Rocca Premature menopause or early menopause: long-term health consequences Maturitas 65 2010 161 166
64. P.M. Maki Potential importance of early initiation of hormone therapy for cognitive benefit Menopause 13 2006 6 7
65. R.A. Whitmer, C.P. Quesenberry, J. Zhou, and K. Yaffe Timing of hormone therapy and dementia: the critical window theory revisited Ann Neurol 69 2011 163 169
66. F. Caraci, C. Busceti, F. Biagioni, E. Aronica, F. Mastroiacovo, and I. Cappuccio The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders Neurochem Res 33 2008 2401 2406
67. Y. Dun, G. Li, Y. Yang, Z. Xiong, M. Feng, and M. Wang Inhibition of the canonical Wnt pathway by Dickkopf-1 contributes to the neurodegeneration in 6-OHDA-lesioned rats Neurosci Lett 525 2012 83 88